| Nutritional status is a prognostic factor for survival in ALS patients JC Desport, PM Preux, TC Truong, JM Vallat, D Sautereau, P Couratier Neurology 53 (5), 1059-1059, 1999 | 613 | 1999 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 592 | 2018 |
| Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues G Logroscino, BJ Traynor, O Hardiman, P Couratier, JD Mitchell, ... Journal of Neurology, Neurosurgery & Psychiatry 79 (1), 6-11, 2008 | 569 | 2008 |
| Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ... The Lancet Neurology 17 (5), 423-433, 2018 | 445 | 2018 |
| Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis JC Desport, PM Preux, L Magy, Y Boirie, JM Vallat, B Beaufrère, ... The American journal of clinical nutrition 74 (3), 328-334, 2001 | 412 | 2001 |
| Hypermetabolism in ALS patients: an early and persistent phenomenon C Bouteloup, JC Desport, P Clavelou, N Guy, H Derumeaux-Burel, ... Journal of neurology 256, 1236-1242, 2009 | 386 | 2009 |
| Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis B Marin, F Boumédiene, G Logroscino, P Couratier, MC Babron, ... International journal of epidemiology 46 (1), 57-74, 2017 | 377 | 2017 |
| TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration L Benajiba, I Le Ber, A Camuzat, M Lacoste, C Thomas‐Anterion, ... Annals of neurology 65 (4), 470-473, 2009 | 358 | 2009 |
| SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype–phenotype correlations S Millecamps, F Salachas, C Cazeneuve, P Gordon, B Bricka, A Camuzat, ... Journal of medical genetics 47 (8), 554-560, 2010 | 351 | 2010 |
| Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients B Marin, JC Desport, P Kajeu, P Jésus, B Nicolaud, M Nicol, PM Preux, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (6), 628-634, 2011 | 321 | 2011 |
| Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ... Nature genetics 53 (12), 1636-1648, 2021 | 294 | 2021 |
| Hypermetabolism in ALS: correlations with clinical and paraclinical parameters JC Desport, F Torny, M Lacoste, PM Preux, P Couratier Neurodegenerative Diseases 2 (3-4), 202-207, 2006 | 275 | 2006 |
| Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors P Couratier, P Sindou, J Hugon, JM Vallat, M Dumas The Lancet 341 (8840), 265-268, 1993 | 253 | 1993 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 245 | 2020 |
| Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study J Gil, B Funalot, A Verschueren, V Danel‐Brunaud, W Camu, ... European journal of neurology 15 (11), 1245-1251, 2008 | 199 | 2008 |
| Ultrastructural PMP22 expression in inherited demyelinating neuropathies JM Vallat, P Sindou, PM Preux, F Tabaraud, AM Milor, P Couratier, ... Annals of neurology 39 (6), 813-817, 1996 | 176 | 1996 |
| High metabolic level in patients with familial amyotrophic lateral sclerosis B Funalot, JC Desport, F Sturtz, W Camu, P Couratier Amyotrophic Lateral Sclerosis 10 (2), 113-117, 2009 | 168 | 2009 |
| Epidemiology of amyotrophic lateral sclerosis: a review of literature P Couratier, P Corcia, G Lautrette, M Nicol, PM Preux, B Marin Revue neurologique 172 (1), 37-45, 2016 | 167 | 2016 |
| The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials E Beghi, A Chiò, P Couratier, J Esteban, O Hardiman, G Logroscino, ... Amyotrophic Lateral Sclerosis 12 (1), 1-10, 2011 | 159 | 2011 |
| Memantine in behavioral variant frontotemporal dementia: negative results M Vercelletto, C Boutoleau-Bretonnière, C Volteau, M Puel, S Auriacombe, ... Journal of Alzheimer's disease 23 (4), 749-759, 2011 | 150 | 2011 |
